Book contents
- Transparency in Health and Health Care in the United States
- Transparency in Health and Health Care in the United States
- Copyright page
- Dedication
- Contents
- Contributors
- Acknowledgments
- Introduction
- Part I Transparency in Health and Health Care: Thematic Issues
- Part II Transparency and Informed Consent
- Part III Transparency and Economics: Health Care Costs and Billing
- Part IV Transparency and Innovation
- Introduction to Part IV
- 12 Increasing the Transparency of FDA Review to Enhance the Innovation Process
- 13 Transparency and Clinical Trial Data Sharing
- 14 The European Medicines Agency’s Approach to Transparency
- Part V Transparency and Outcomes: Promoting Health and Safety
- Part VI Challenges in Promoting and Measuring Transparency in Health Care
12 - Increasing the Transparency of FDA Review to Enhance the Innovation Process
from Part IV - Transparency and Innovation
Published online by Cambridge University Press: 19 June 2019
- Transparency in Health and Health Care in the United States
- Transparency in Health and Health Care in the United States
- Copyright page
- Dedication
- Contents
- Contributors
- Acknowledgments
- Introduction
- Part I Transparency in Health and Health Care: Thematic Issues
- Part II Transparency and Informed Consent
- Part III Transparency and Economics: Health Care Costs and Billing
- Part IV Transparency and Innovation
- Introduction to Part IV
- 12 Increasing the Transparency of FDA Review to Enhance the Innovation Process
- 13 Transparency and Clinical Trial Data Sharing
- 14 The European Medicines Agency’s Approach to Transparency
- Part V Transparency and Outcomes: Promoting Health and Safety
- Part VI Challenges in Promoting and Measuring Transparency in Health Care
Summary
- Type
- Chapter
- Information
- Transparency in Health and Health Care in the United StatesLaw and Ethics, pp. 185 - 195Publisher: Cambridge University PressPrint publication year: 2019